These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 10481667

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS, McClure BG, Tubman TR.
    BMJ; 1998 May 23; 316(7144):1611. PubMed ID: 9616034
    [No Abstract] [Full Text] [Related]

  • 23. Kleihauer testing. Need not be abandoned.
    Love EM, Shwe KH.
    BMJ; 1994 Sep 24; 309(6957):805. PubMed ID: 7950581
    [No Abstract] [Full Text] [Related]

  • 24. Kleihauer testing. Quality assurance scheme exists.
    Urbaniak SJ, Main R, Fraser N.
    BMJ; 1994 Sep 24; 309(6957):805. PubMed ID: 7950582
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Rhesus sensitisation.
    Allan A.
    Mod Midwife; 1995 Nov 24; 5(11):24-6. PubMed ID: 7583418
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Preventing RhD haemolytic disease of the newborn. New recommendations must be explained to GPs and midwives.
    Everett C, Wray J.
    BMJ; 1998 Apr 11; 316(7138):1165. PubMed ID: 9569419
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Prevention of Rh immunization. I. Theoretical background and management of the risk during the first half of pregnancy].
    Larsen JF, Bock JE, Jørgensen JR.
    Ugeskr Laeger; 2004 Aug 30; 166(36):3073-8. PubMed ID: 15387303
    [No Abstract] [Full Text] [Related]

  • 34. Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years.
    MacKenzie IZ, Findlay J, Thompson K, Roseman F.
    BJOG; 2006 Jul 30; 113(7):839-43. PubMed ID: 16827770
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Rho (D) immune globulin i.v. for prevention of Rh isoimmunization and for treatment of ITP.
    Med Lett Drugs Ther; 1996 Jan 19; 38(966):6-8. PubMed ID: 8544794
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Rh-immunoglobulin: Rh prophylaxis.
    Bowman J.
    Best Pract Res Clin Haematol; 2006 Jan 19; 19(1):27-34. PubMed ID: 16377539
    [No Abstract] [Full Text] [Related]

  • 39. Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin.
    Laspina S, O'riordan JM, Lawlor E, Murphy WG.
    Vox Sang; 2005 Jul 19; 89(1):49-51. PubMed ID: 15938740
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.